16(top 5%)
papers
294(top 5%)
citations
7(top 5%)
h-index
14(top 2%)
g-index
23
all documents
356
doc citations
167
citing journals

Top Articles

#TitleJournalYearCitations
1Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR databaseAnnals of the Rheumatic Diseases2021160
2Azacitidine for patients with Vacuoles, E1 Enzyme, X‐linked, Autoinflammatory, Somatic syndrome (VEXAS) and myelodysplastic syndrome: data from the French VEXAS registryBritish Journal of Haematology202285
3Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry diseaseClinical Genetics202226
4Granulomatosis with polyangiitis: Study of 795 patients from the French Vasculitis Study Group registrySeminars in Arthritis and Rheumatism202122
5Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortRheumatology202014
6Positive Impact of Expert Reference Center Validation on Performance of Next-Generation Sequencing for Genetic Diagnosis of Autoinflammatory DiseasesJournal of Clinical Medicine20199
7Epidemiology of Idiopathic Inflammatory Myopathies in AfricaJournal of Clinical Rheumatology20228
8Practical management of patients on hydroxychloroquineJoint Bone Spine20218
9Exploring patient education unmet needs for rare and complex connective tissue and musculoskeletal diseases: A survey of health care providers’ and patients’ expectations in EuropeChronic Illness20205
10Epidemiology of Sjögren Syndrome in AfricaJournal of Clinical Rheumatology20223
11Systemic Pulmonary Events Associated with Myelodysplastic Syndromes: A Retrospective Multicentre StudyJournal of Clinical Medicine20213
12Correspondence in reference to the previously published Epub manuscript: immune thrombocytopenic purpura after SARS‐CoV‐2 vaccineBritish Journal of Haematology20213
13Epidemiological data on systemic lupus erythematosus in native sub-Saharan AfricansData in Brief20202
14Effective Anti–SARS-CoV-2 Immune Response in Patients With Clonal Mast Cell DisordersJournal of Allergy and Clinical Immunology: in Practice20222
15OP0239 PROGRESSIVE LUNG FIBROSIS IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE IN THE EUSTAR DATABASEJournal of Allergy and Clinical Immunology: in Practice20191
16Prediction and Frequency of Progressive Lung Fibrosis in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease in the World’s Largest Database of Patients with Systemic Sclerosis (EUSTAR)Journal of Allergy and Clinical Immunology: in Practice20191
17Disease course and outcome of progressive interstitial lung disease in systemic sclerosisJournal of Allergy and Clinical Immunology: in Practice20191
18Neuralgic amyotrophy triggered by cytomegalovirus: to be aware of this clinical diagnosisNeurocase20221
19FRI0325 IDENTIFYING SYSTEMIC SCLEROSIS PATIENTS AT RISK OF PROGRESSIVE LUNG FIBROSIS – A EUSTAR DATABASE ANALYSISNeurocase20190
20Feasibility and Efficacy of Cohort Enrichment for Progressive Lung Fibrosis in Systemic Sclerosis - a EUSTAR Database AnalysisNeurocase20190
21Efficacy and Safety of Nintedanib in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analysis of the SENSCIS Trial by Corticosteroid Use*Pneumologie20200
22POS0387 RISK STRATIFICATION APPROACHES PERFORM DIFFERENTLY IN SSc-ASSOCIATED PAH IN EUSTARAnnals of the Rheumatic Diseases20220